Magnesium Sulphate Injection
General Notices
DEFINITION
Magnesium Sulphate Injection is a sterile solution of Magnesium Sulphate Heptahydrate in
Water for Injections.
The injection complies with the requirements stated under Parenteral Preparations and with
the following requirements.
Content of magnesium sulphate heptahydrate, MgSO4,7H2O
95.0 to 105.0% of the stated amount.
CHARACTERISTICS
A clear, colourless solution.
IDENTIFICATION
Yields the reactions characteristic of magnesium salts and of sulphates, Appendix VI.
TESTS
Acidity or alkalinity
pH of the injection diluted, if necessary, to contain 5% w/v of Magnesium Sulphate
Heptahydrate, 5.5 to 7.0, Appendix V L.
ASSAY
Dilute a volume containing 1.25 g of Magnesium Sulphate Heptahydrate to 100 ml with water.
To 20 ml of this solution add 10 ml of ammonia buffer pH 10.9 and titrate with 0.05M disodium
edetate VS using 0.1 g of mordant black 11 triturate as indicator, until the pink tint is
discharged from the blue colour. Each ml of 0.05M disodium edetate VS is equivalent to 12.32
mg of MgSO4,7H2O.
LABELLING
The strength is stated as the percentage w/v
of Magnesium Sulphate Heptahydrate and as
the approximate concentration of magnesium ions (Mg2+) in millimoles per ml.
For a preparation containing 50% w/v
of Magnesium Sulphate Heptahydrate (MgSO4,7H2O)
the concentration of magnesium ions is approximately 2 millimoles per millilitre (2 mmol Mg2+/
ml).